Correlation Between PAVmed Series and Clearpoint Neuro

Can any of the company-specific risk be diversified away by investing in both PAVmed Series and Clearpoint Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PAVmed Series and Clearpoint Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PAVmed Series Z and Clearpoint Neuro, you can compare the effects of market volatilities on PAVmed Series and Clearpoint Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PAVmed Series with a short position of Clearpoint Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of PAVmed Series and Clearpoint Neuro.

Diversification Opportunities for PAVmed Series and Clearpoint Neuro

0.42

Correlation Coefficient

PAVmed Series  Clearpoint Neuro

Very weak diversification

The 3 months correlation between PAVmed and Clearpoint is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding PAVmed Series Z and Clearpoint Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearpoint Neuro and PAVmed Series is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PAVmed Series Z are associated (or correlated) with Clearpoint Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearpoint Neuro has no effect on the direction of PAVmed Series i.e., PAVmed Series and Clearpoint Neuro go up and down completely randomly.

Pair Corralation between PAVmed Series and Clearpoint Neuro

Assuming the 90 days horizon PAVmed Series Z is expected to generate 6.32 times more return on investment than Clearpoint Neuro. However, PAVmed Series is 6.32 times more volatile than Clearpoint Neuro. It trades about 0.11 of its potential returns per unit of risk. Clearpoint Neuro is currently generating about -0.05 per unit of risk. If you would invest  0.99  in PAVmed Series Z on December 29, 2024 and sell it today you would lose (0.34) from holding PAVmed Series Z or give up 34.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	93.44%
Values	Daily Returns

PAVmed Series Z  vs.  Clearpoint Neuro

PAVmed Series Z

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Series Z are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, PAVmed Series showed solid returns over the last few months and may actually be approaching a breakup point.

Clearpoint Neuro

Risk-Adjusted Performance

Very Weak

Over the last 90 days Clearpoint Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with PAVmed Series and Clearpoint Neuro

The main advantage of trading using opposite PAVmed Series and Clearpoint Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PAVmed Series position performs unexpectedly, Clearpoint Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearpoint Neuro will offset losses from the drop in Clearpoint Neuro's long position.

The idea behind PAVmed Series Z and Clearpoint Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.